基因载体市场 - 按载体（质粒DNA、腺相关病毒、逆转录病毒）、按应用（基因治疗、疫苗学）、按疾病（肿瘤、遗传、感染）、按终端用户（CDMO、CRO、制药和生物技术公司），全球预测2023-2032年

到2032年，全球基因载体市场规模将显著扩大。临床试验数量的增长将为行业增长铺平道路。许多临床试验都在探索联合疗法的潜力，即基因疗法与化疗、放疗或免疫疗法等其他治疗方式相结合。这些组合方法通常涉及使用多种基因载体来提供不同的治疗药物或增强治疗的协同作用。临床试验中对联合疗法的探索日益增多，促进了对基因载体的更高需求。

整个基因载体市场根据载体、应用、疾病、终端用户和地区进行分类。

根据载体，慢病毒细分市场的行业份额将在2023年至2032年期间以可观的复合年增长率增长。基因治疗领域不断增加的投资将为该细分市场的增长带来有利可图的机会。慢病毒载体被广泛用作向靶细胞传递基因的载体。慢病毒载体可有效地将治疗基因等遗传物质转移到各种细胞类型中，包括非分裂或缓慢分裂的细胞。这种能力使其在基因治疗中具有重要价值，可用于治疗遗传性疾病。

基于疾病，从2023年到2032年，传染病领域的行业份额将以显著的复合年增长率增长。传染病的日益流行增加了对基因载体的需求。基因载体可用于开发预防传染性疾病的疫苗。它们可以将特定的抗原基因传递到宿主细胞中，引发免疫反应并产生保护性抗体。这种方法的优势在于能够产生广泛的免疫反应，包括细胞免疫，并具有快速开发新发传染病疫苗的潜力。

根据终端用户的不同，到2032年，CRO行业的产值将大幅增长。CRO数量的增加有助于该细分市场的增长。此外，这些机构在开发基因疗法方面的努力正在进一步推动该细分市场的扩张。CRO利用基因载体进行临床前研究，以评估潜在基因疗法或基于基因的治疗方法的安全性和有效性。

从区域来看，2023年至2032年，亚太地区基因载体市场份额将以指数级复合年增长率增长。HIV/AIDS等传染性疾病的不断增加增加了该地区对基因载体的需求。此外，快速发展的医疗基础设施也进一步促进了该地区的增长。根据IBEF的数据，在2023-24年的联邦预算中，印度政府向卫生和家庭福利部拨款107.6亿美元。

目录

第1章：方法与范围

第二章：执行摘要

第三章 基因载体市场洞察

• 行业生态系统分析
• 行业影响因素
  • 增长驱动力
    • 遗传疾病、癌症和传染病发病率上升
    • 更先进的基因编辑技术的发展
    • 个性化医疗需求增加
    • 用于开发基因疗法的研发投资增加
    • 对基于病毒载体的基因疗法的持续研究
  • 行业陷阱与挑战
    • 基因治疗的高成本
    • 与基因载体开发监管审批相关的挑战
• 增长潜力分析
  • 按载体类型
  • 按应用
  • 按疾病
  • 按最终用户
• COVID-19影响分析
• 技术分析
• 监管概况
  • 美国
  • 欧洲
• 波特分析
• PESTEL分析

第四章：2022年竞争格局

• 公司介绍
• 2022年公司矩阵分析
• 2022年市场份额分析
• 竞争定位矩阵
• 战略仪表板

第五章：基因载体市场规模及预测：按载体类型分类

• 按载体类型分類的主要趋势
• 质粒DNA
• 逆转录病毒
• 慢病毒
• 腺病毒
• 腺相关病毒
• 其他载体类型

第六章：基因载体市场规模及预测：按应用分类

• 按应用分类的主要趋势
• 基因治疗
• 疫苗学
• 其他应用

第七章 ：基因载体市场规模及预测：按疾病分类

• 按疾病分类的主要趋势
• 肿瘤
• 遗传性疾病
• 传染病
• 其他疾病

第八章：基因载体市场规模及预测：按最终用户分类

• 按最终用户分類的主要趋势
• CDMO公司
• 制药和生物技术公司
• 研究机构
• CRO公司

第九章：基因载体市场规模及预测：按地区分类

• 各地区主要趋势
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳大利亚和新西兰
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 中东和非洲其他地区

第10章：公司简介

• Lonza
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Oxford Biomedica
• Cobra Biologics
• Novasep
• Spark Therapeutics
• Kaneka Eurogentec
• Finvector Vision Therapies
• Brammer Bio
• Cell and Gene Therapy Catapult
• FUJIFILM Diosynth Biotechnologies
• uniQure N.V.

Global Gene Vector Market size will expand considerably through 2032. Growing number of clinical trials will pave the way for industry growth. Many clinical trials explore the potential of combination therapies, where gene therapy is combined with other treatment modalities such as chemotherapy, radiation therapy, or immunotherapy. These combination approaches often involve the use of multiple gene vectors to deliver different therapeutic agents or enhance treatment synergies. The increasing exploration of combination therapies in clinical trials contributes to the higher demand for gene vectors.

The overall gene vector market is classified based on vector, application, diseases, end-user, and region.

Based on the vector, industry share from the lentiviral segment will grow at a substantial CAGR from 2023 to 2032. Increasing investment in gene therapy will generate lucrative opportunities for segment growth. Lentiviral vectors are widely used as vehicles for delivering genes into target cells. They can efficiently transfer genetic material, such as therapeutic genes, to a range of cell types, including non-dividing or slowly dividing cells. This ability makes them valuable in gene therapy, where they are used to treat genetic disorders.

Based on diseases, industry share from the infectious disease segment will grow at a significant CAGR from 2023 to 2032. Growing prevalence of infectious diseases has increased the demand for gene vectors. Gene vectors can be used to develop vaccines against infectious diseases. They can deliver specific antigen genes into host cells, triggering an immune response and the production of protective antibodies. This approach offers advantages such as the ability to generate a broad immune response, including cellular immunity, and the potential to rapidly develop vaccines for emerging infectious diseases.

Based on the end-user, industry value from the CROs segment will register significant gains through 2032. Increasing number of CROs is contributing to segment growth. Moreover, rising efforts by these organizations toward the development of gene therapies are further creating a notable impetus for segment expansion. CROs conduct preclinical studies using gene vectors to assess the safety and efficacy of potential gene therapies or gene-based treatments.

Regionally, the Asia Pacific gene vector market share will grow at an exponential CAGR from 2023 to 2032. Growing occurrence of infectious disorders such as HIV/AIDS has increased the demand for gene vectors in the region. Moreover, rapidly expanding healthcare infrastructure is further contributing to regional growth. As per IBEF, in the Union Budget 2023-24, the government of India awarded USD 10.76 billion to the Ministry of Health and Family Welfare.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Data Sources
  • 1.4.1 Secondary
    • 1.4.1.1 Paid sources
    • 1.4.1.2 Public sources
  • 1.4.2 Primary

Chapter 2 Executive Summary

• 2.1 Gene vector 360 degree synopsis, 2018 - 2032
• 2.2 Business trends
• 2.3 Vector type trends
• 2.4 Application trends
• 2.5 Disease trends
• 2.6 End user trends

Chapter 3 Gene Vector Market Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of genetic disorders, cancer, and infectious diseases
    • 3.2.1.2 Development of more advanced gene editing technologies
    • 3.2.1.3 Increasing demand for personalized medicine
    • 3.2.1.4 Increase in R&D investments for the development of gene therapy
    • 3.2.1.5 Ongoing research into viral vector-based gene therapies
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of gene therapies
    • 3.2.2.2 Challenges associated with regulatory approval of gene vectors development
• 3.3 Growth potential analysis
  • 3.3.1 By vector type
  • 3.3.2 By application
  • 3.3.3 By disease
  • 3.3.4 By end user
• 3.4 COVID- 19 impact analysis
• 3.5 Technological analysis
• 3.6 Regulatory landscape
  • 3.6.1 U.S.
  • 3.6.2 Europe
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Market share analysis , 2022
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Gene Vector Market Size and Forecast, By Vector Type (USD Million)

• 5.1 Key trends, by vector type
• 5.2 Plasmid DNA
• 5.3 Retroviral
• 5.4 Lentiviral
• 5.5 Adenoviral
• 5.6 Adeno-associated viral
• 5.7 Other vector types

Chapter 6 Gene Vector Market Size and Forecast, By Application (USD Million)

• 6.1 Key trends, by application
• 6.2 Gene therapy
• 6.3 Vaccinology
• 6.4 Other applications

Chapter 7 Gene Vector Market Size and Forecast, By Disease (USD Million)

• 7.1 Key trends, by disease
• 7.2 Oncology
• 7.3 Genetic disorders
• 7.4 Infectious diseases
• 7.5 Other diseases

Chapter 8 Gene Vector Market Size and Forecast, By End-user (USD Million)

• 8.1 Key trends, by end-user
• 8.2 CDMOs
• 8.3 Pharmaceutical and biotechnology companies
• 8.4 Research institutes
• 8.5 CROs

Chapter 9 Gene Vector Market Size and Forecast, By Region (USD Million)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia and New Zealand
  • 9.4.5 Rest of Asia pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 MEA
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

• 10.1 Lonza
• 10.2 Merck KGaA
• 10.3 Thermo Fisher Scientific Inc.
• 10.4 Oxford Biomedica
• 10.5 Cobra Biologics
• 10.6 Novasep
• 10.7 Spark Therapeutics
• 10.8 Kaneka Eurogentec
• 10.9 Finvector Vision Therapies
• 10.10 Brammer Bio
• 10.11 Cell and Gene Therapy Catapult
• 10.12 FUJIFILM Diosynth Biotechnologies
• 10.13 uniQure N.V.

Data Tables

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by vector type (2022)
• TABLE 3 Market revenue, by application (2022)
• TABLE 4 Market share, by disease2022)
• TABLE 5 Market share, by end-user (2022)
• TABLE 6 Market share, by region (2022)
• TABLE 7 Global gene vector market size, by region, 2018 - 2022 (USD Million)
• TABLE 8 Global gene vector market size, by region, 2023 - 2032 (USD Million)
• TABLE 9 Global gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 10 Global gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 11 Global gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 12 Global gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 13 Global gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 14 Global gene vector market size, by disease 2023 - 2032 (USD Million)
• TABLE 15 Global gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 16 Global gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 17 Industry impact forces
• TABLE 18 Competitive benchmarking of major market players
• TABLE 19 Competitive positioning matrix: classification criteria
• TABLE 20 Strategic outlook matrix: classification criteria
• TABLE 21 Plasmid DNA market size, 2018 - 2022 (USD Million)
• TABLE 22 Plasmid DNA market size, 2023 - 2032 (USD Million)
• TABLE 23 Adenoviral market size, 2018 - 2022 (USD Million)
• TABLE 24 Adenoviral market size, 2023 - 2032 (USD Million)
• TABLE 25 Adeno-associated viral market size, 2018 - 2022 (USD Million)
• TABLE 26 Adeno-associated viral market size, 2023 - 2032 (USD Million)
• TABLE 27 Retroviral market size, 2018 - 2022 (USD Million)
• TABLE 28 Retroviral market size, 2023 - 2032 (USD Million)
• TABLE 29 Lentiviral market size, 2018 - 2022 (USD Million)
• TABLE 30 Lentiviral market size, 2023 - 2032 (USD Million)
• TABLE 31 Other vector types market size, 2018 - 2022 (USD Million)
• TABLE 32 Other vector types market size, 2023 - 2032 (USD Million)
• TABLE 33 Gene therapy market size, 2018 - 2022 (USD Million)
• TABLE 34 Gene therapy market size, 2023 - 2032 (USD Million)
• TABLE 35 Vaccinology market size, 2018 - 2022 (USD Million)
• TABLE 36 Vaccinology market size, 2023 - 2032 (USD Million)
• TABLE 37 Other applications market size, 2018 - 2022 (USD Million)
• TABLE 38 Other applications market size, 2023 - 2032 (USD Million)
• TABLE 39 Oncology market size, 2018 - 2022 (USD Million)
• TABLE 40 Oncology market size, 2023 - 2032 (USD Million)
• TABLE 41 Genetic disorders market size, 2018 - 2022 (USD Million)
• TABLE 42 Genetic disorders market size, 2023 - 2032 (USD Million)
• TABLE 43 Infectious diseases market size, 2018 - 2022 (USD Million)
• TABLE 44 Infectious diseases market size, 2023 - 2032 (USD Million)
• TABLE 45 Other diseases market size, 2018 - 2022 (USD Million)
• TABLE 46 Other diseases market size, 2023 - 2032 (USD Million)
• TABLE 47 CDMOs market size, 2018 - 2022 (USD Million)
• TABLE 48 CDMOs market size, 2023 - 2032 (USD Million)
• TABLE 49 Pharmaceutical and biotechnology companies market size, 2018 - 2022 (USD Million)
• TABLE 50 Pharmaceutical and biotechnology companies market size, 2023 - 2032 (USD Million)
• TABLE 51 Research institutes market size, 2018 - 2022 (USD Million)
• TABLE 52 Research institutes market size, 2023 - 2032 (USD Million)
• TABLE 53 CROs market size, 2018 - 2022 (USD Million)
• TABLE 54 CROs market size, 2023 - 2032 (USD Million)
• TABLE 55 North America gene vector Market size, by country, 2018 - 2022 (USD Million)
• TABLE 56 North America gene vector Market size, by country, 2023 - 2032 (USD Million)
• TABLE 57 North America gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 58 North America gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 59 North America gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 60 North America gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 61 North America gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 62 North America gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 63 North America gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 64 North America gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 65 U.S. gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 66 U.S. gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 67 U.S. gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 68 U.S. gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 69 U.S. gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 70 U.S. gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 71 U.S. gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 72 U.S. gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 73 Canada gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 74 Canada gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 75 Canada gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 76 Canada gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 77 Canada gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 78 Canada gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 79 Canada gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 80 Canada gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 81 Europe gene vector Market size, by country, 2018 - 2022 (USD Million)
• TABLE 82 Europe gene vector Market size, by country, 2023 - 2032 (USD Million)
• TABLE 83 Europe gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 84 Europe gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 85 Europe gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 86 Europe gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 87 Europe gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 88 Europe gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 89 Europe gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 90 Europe gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 91 Germany gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 92 Germany gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 93 Germany gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 94 Germany gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 95 Germany gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 96 Germany gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 97 Germany gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 98 Germany gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 99 UK gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 100 UK gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 101 UK gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 102 UK gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 103 UK gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 104 UK gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 105 UK gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 106 UK gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 107 France gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 108 France gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 109 France gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 110 France gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 111 France gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 112 France gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 113 France gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 114 France gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 115 Italy gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 116 Italy gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 117 Italy gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 118 Italy gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 119 Italy gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 120 Italy gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 121 Italy gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 122 Italy gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 123 Spain gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 124 Spain gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 125 Spain gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 126 Spain gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 127 Spain gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 128 Spain gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 129 Spain gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 130 Spain gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 131 Rest of Europe gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 132 Rest of Europe gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 133 Rest of Europe gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 134 Rest of Europe gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 135 Rest of Europe gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 136 Rest of Europe gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 137 Rest of Europe gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 138 Rest of Europe gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 139 Asia Pacific gene vector Market size, by country, 2018 - 2022 (USD Million)
• TABLE 140 Asia Pacific gene vector Market size, by country, 2023 - 2032 (USD Million)
• TABLE 141 Asia Pacific gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 142 Asia Pacific gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 143 Asia Pacific gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 144 Asia Pacific gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 145 Asia Pacific gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 146 Asia Pacific gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 147 Asia Pacific gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 148 Asia Pacific gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 149 China gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 150 China gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 151 China gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 152 China gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 153 China gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 154 China gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 155 China gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 156 China gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 157 Japan gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 158 Japan gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 159 Japan gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 160 Japan gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 161 Japan gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 162 Japan gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 163 Japan gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 164 Japan gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 165 India gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 166 India gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 167 India gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 168 India gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 169 India gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 170 India gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 171 India gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 172 India gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 173 Australia & The Newzealand gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 174 Australia & The Newzealand gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 175 Australia & The Newzealand gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 176 Australia & The Newzealand gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 177 Australia & The Newzealand gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 178 Australia & The Newzealand gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 179 Australia & The Newzealand gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 180 Australia & The Newzealand gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 181 Rest of APAC gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 182 Rest of APAC gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 183 Rest of APAC gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 184 Rest of APAC gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 185 Rest of APAC gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 186 Rest of APAC gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 187 Rest of APAC gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 188 Rest of APAC gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 189 Latin America gene vector Market size, by country, 2018 - 2022 (USD Million)
• TABLE 190 Latin America gene vector Market size, by country, 2023 - 2032 (USD Million)
• TABLE 191 Latin America gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 192 Latin America gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 193 Latin America gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 194 Latin America gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 195 Latin America gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 196 Latin America gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 197 Latin America gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 198 Latin America gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 199 Brazil gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 200 Brazil gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 201 Brazil gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 202 Brazil gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 203 Brazil gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 204 Brazil gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 205 Brazil gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 206 Brazil gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 207 Mexico gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 208 Mexico gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 209 Mexico gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 210 Mexico gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 211 Mexico gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 212 Mexico gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 213 Mexico gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 214 Mexico gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 215 Rest of Latin America gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 216 Rest of Latin America gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 217 Rest of Latin America gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 218 Rest of Latin America gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 219 Rest of Latin America gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 220 Rest of Latin America gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 221 Rest of Latin America gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 222 Rest of Latin America gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 223 Middle East & Africa gene vector Market size, by country, 2018 - 2022 (USD Million)
• TABLE 224 Middle East & Africa gene vector Market size, by country, 2023 - 2032 (USD Million)
• TABLE 225 Middle East & Africa gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 226 Middle East & Africa gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 227 Middle East & Africa gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 228 Middle East & Africa gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 229 Middle East & Africa gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 230 Middle East & Africa gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 231 Middle East & Africa gene vector market size, by end user, 2018 - 2022 (USD Million)
• TABLE 232 Middle East & Africa gene vector market size, by end user, 2023 - 2032 (USD Million)
• TABLE 233 South Africa gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 234 South Africa gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 235 South Africa gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 236 South Africa gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 237 South Africa gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 238 South Africa gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 239 South Africa gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 240 South Africa gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 241 Saudi Arabia gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 242 Saudi Arabia gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 243 Saudi Arabia gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 244 Saudi Arabia gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 245 Saudi Arabia gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 246 Saudi Arabia gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 247 Saudi Arabia gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 248 Saudi Arabia gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 249 Rest of MEA gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 250 Rest of MEA gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 251 Rest of MEA gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 252 Rest of MEA gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 253 Rest of MEA gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 254 Rest of MEA gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 255 Rest of MEA gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 256 Rest of MEA gene vector market size, by end-user, 2023 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Gene vector industry 36 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by vector type
• FIG 8 Growth potential analysis, by application
• FIG 9 Growth potential analysis, by disease
• FIG 10 Growth potential analysis, by end-use
• FIG 11 Porter's analysis
• FIG 12 PESTEL analysis
• FIG 13 Competitive dashboard, 2022
• FIG 14 Company matrix analysis, 2022
• FIG 15 Competitive analysis of major market players, 2022
• FIG 16 Competitive positioning matrix
• FIG 17 Strategic outlook matrix